Breast cancer chemoprevention: Drugs that reduce risk

Preventive medications can reduce breast cancer risk. Learn about how these drugs work, who should consider taking them, plus their side effects and health risks.

By Mayo Clinic Staff

If you're at high risk of breast cancer, you may be able to improve your odds of staying cancer-free by taking certain medicines — an approach known as chemoprevention or preventive therapy.

Medications for breast cancer chemoprevention are the subject of much ongoing research.

Here's a look at what's known about each of these medications, including how they may work to prevent breast cancer and the possible side effects and health risks.

Tamoxifen

How it works

Tamoxifen blocks the effects of estrogen — a reproductive hormone that influences the growth and development of many breast cancers.

Tamoxifen belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). The drug reduces the effects of estrogen in most areas of the body, including the breast. In the uterus, however, tamoxifen acts like an estrogen and encourages the growth of the lining of the uterus.

Tamoxifen is usually prescribed as a pill taken once a day by mouth. For breast cancer risk reduction, tamoxifen is typically taken for a total of five years. The risk reduction benefit continues for five additional years after you stop taking tamoxifen. In total, you could receive up to 10 years of benefit.

Who it's for

Tamoxifen is used to reduce the risk of invasive breast cancer if you're at high risk and you're 35 and older, whether or not you've gone through menopause.

You and your health care provider might consider whether chemoprevention with tamoxifen is right for you if:

  • Your Gail model risk score is greater than 1.7%. The Gail model is a tool that health care providers use to predict future risk of developing breast cancer. The risk score is based on factors such as age, reproductive history and family history.
  • You're at high risk of developing breast cancer. For instance, you've had a breast biopsy that found a precancerous condition such as lobular carcinoma in situ, atypical ductal hyperplasia or atypical lobular hyperplasia.
  • You have a strong family history of breast cancer.
  • You don't have a history of blood clots.

Common side effects

Common side effects of tamoxifen include:

  • Hot flashes
  • Night sweats
  • Vaginal discharge
  • Vaginal dryness

Risks

Rarely, taking tamoxifen may cause:

  • Blood clots
  • Endometrial cancer or uterine cancer
  • Cataracts
  • Stroke

If you haven't undergone menopause, the risk of uterine cancer when taking tamoxifen is very low compared with the risk for those who have already undergone menopause. In this situation, the benefits of tamoxifen may outweigh the risks if you have an increased risk of breast cancer due to a strong family history or a personal history of precancerous breast changes.

If you've undergone menopause, the benefits of tamoxifen may outweigh the risks if you have an increased risk of breast cancer and have also had surgery to remove your uterus (hysterectomy).

Raloxifene

How it works

Raloxifene (Evista) is another drug in the class known as SERMs. It's also prescribed in pill form, to be taken by mouth once a day for five years.

Like tamoxifen, raloxifene works by blocking estrogen's effects in the breast and other tissues. Unlike tamoxifen, raloxifene doesn't exert estrogen-like effects on the uterus.

Who it's for

Raloxifene is used to reduce the risk of invasive breast cancer if you're at high risk and you've undergone menopause (postmenopausal). You're considered at high risk if you score greater than 1.7% on the Gail model.

Raloxifene is also used for prevention and treatment of the bone-thinning disease osteoporosis in those who've undergone menopause.

Common side effects

Common side effects of raloxifene include:

  • Hot flashes
  • Vaginal dryness or irritation
  • Joint and muscle pain
  • Weight gain

Risks

Health risks associated with raloxifene are similar to those associated with tamoxifen.

Both drugs carry an increased risk of blood clots, though the risk may be lower with raloxifene. Raloxifene may be associated with fewer instances of endometrial and uterine cancers than is tamoxifen.

Raloxifene may also be linked to fewer strokes than tamoxifen in people at average risk of heart disease. But if you have heart disease or you have multiple risk factors for heart disease, raloxifene may increase your risk of strokes.

Although tamoxifen may be slightly better than raloxifene at reducing the risk of breast cancer, the risk of blood clots and uterine cancer are lower with raloxifene. For this reason, raloxifene may be a preferred option if you've undergone menopause and haven't had a hysterectomy or have osteoporosis.

Aromatase inhibitors

Aromatase inhibitors are commonly used to treat breast cancer that's hormone receptor positive. These drugs are also an option for breast cancer chemoprevention.

How they work

Aromatase inhibitors are a class of medicines that reduce the amount of estrogen in your body, depriving breast cancer cells of the fuel they need to grow and thrive.

Three aromatase inhibitors are currently approved in the United States for breast cancer treatment: anastrozole (Arimidex), exemestane (Aromasin) and letrozole (Femara).

These medications are used to treat breast cancer that's estrogen- or progesterone-responsive in those who've undergone menopause.

Who they're for

Aromatase inhibitors have been studied and shown to be effective to treat breast cancer and to prevent breast cancer recurrence after menopause. Aromatase inhibitors are not intended for preventing breast cancer recurrence if you still have menstrual cycles.

Aromatase inhibitors, specifically exemestane and anastrozole, have also been studied to see if they may reduce the risk of breast cancer in people at high risk, such as those with a family history of breast cancer or a history of precancerous breast lesions. Studies have shown promise in reducing breast cancer risk in these individuals.

Based on these results, you and your health care provider may choose to use aromatase inhibitors to reduce the risk of breast cancer, though these drugs aren't approved by the U.S. Food and Drug Administration for this use.

Additional studies are underway to determine whether aromatase inhibitors may reduce the risk of breast cancer in those with genetic mutations that increase the risk of breast cancer.

Common side effects

Common side effects of aromatase inhibitors include:

  • Hot flashes
  • Vaginal dryness
  • Joint and muscle pain
  • Headache
  • Fatigue

Risks

Aromatase inhibitors increase the risk of osteoporosis.

Aromatase inhibitors aren't associated with an increased risk of blood clots or uterine cancer, as tamoxifen and raloxifene are. Because aromatase inhibitors are a newer class of medications, more research needs to be done about long-term health risks, such as heart disease and broken bones.

As more results from research studies become available, health care providers will have a better idea of the long-term health implications for these drugs and their effectiveness in breast cancer chemoprevention.

Get the latest health information from Mayo Clinic’s experts.

Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Oct. 19, 2021 See more In-depth

See also

  1. 3D mammogram
  2. Alternative and complementary medicine for metastatic breast cancer
  3. Biopsy procedures
  4. Blood Basics
  5. Bone scan
  6. Brachytherapy
  7. BRCA gene test
  8. Breast cancer
  9. Breast Cancer Education Tool
  10. Common questions about breast cancer treatment
  11. Breast cancer prevention
  12. Breast cancer radiation: Can it cause dry skin?
  13. Infographic: Breast Cancer Risk
  14. Breast cancer staging
  15. Breast cancer supportive therapy and survivorship
  16. Breast cancer surgery
  17. Breast cancer types
  18. Breast implants: Do they interfere with mammograms?
  19. Breast implants and cancer
  20. Evaluating breast lumps
  21. Breast lumps
  22. Breast MRI
  23. Infographic: Breast Reconstruction Options
  24. Breast self-exam for breast awareness
  25. Chemo Targets
  26. Chemotherapy
  27. Chemotherapy and hair loss: What to expect during treatment
  28. Chemotherapy and sex: Is sexual activity OK during treatment?
  29. Chemotherapy for breast cancer
  30. Chemotherapy nausea and vomiting: Prevention is best defense
  31. Chest X-rays
  32. Complete blood count (CBC)
  33. Conflicting mammogram results: What can I do?
  34. Coping with pain after breast surgery
  35. COVID-19 vaccine: Should I reschedule my mammogram?
  36. CT scan
  37. CT scans: Are they safe?
  38. Dense breast tissue
  39. Does soy really affect breast cancer risk?
  40. Dragon Boats and Breast Cancer
  41. Gene expression profiling for breast cancer: What is it?
  42. Genetic Testing for Breast Cancer
  43. Genetic testing for breast cancer: Psychological and social impact
  44. Get ready for possible side effects of chemotherapy
  45. Get the support you need when you have metastatic breast cancer
  46. Ginger for nausea: Does it work?
  47. Hormone therapy for breast cancer
  48. Metastatic breast cancer
  49. Lower your risk of breast cancer
  50. Lumpectomy
  51. Magic mouthwash
  52. Mammogram
  53. Mammogram: Can it find cancer in dense breasts?
  54. Mammogram guidelines: What are they?
  55. Mastectomy
  56. Metastatic breast cancer: Should you get a second opinion?
  57. Modified radical mastectomy
  58. Molecular breast imaging
  59. Infographic: Molecular Breast Imaging
  60. MRI
  61. MRI-guided breast biopsy
  62. What is breast cancer? An expert explains
  63. Nipple discharge
  64. Nipple-sparing mastectomy
  65. Oncoplastic breast surgery
  66. Palliative care for metastatic breast cancer
  67. Palliative care: Who is it for?
  68. PALS (Pets Are Loving Support)
  69. Paulas story A team approach to battling breast cancer
  70. Pink Sisters
  71. Positron emission mammography (PEM)
  72. Positron emission tomography scan
  73. Precision medicine for breast cancer
  74. Preventive (prophylactic) mastectomy
  75. Prophylactic oophorectomy: Preventing cancer by surgically removing your ovaries
  76. Radiation therapy
  77. Radiation therapy for breast cancer
  78. Relationships and metastatic breast cancer
  79. Infographic: Scalp Cooling Therapy for Cancer
  80. Seeing inside the heart with MRI
  81. Sentinel node biopsy
  82. Skin-sparing mastectomy
  83. Stereotactic breast biopsy
  84. Support groups
  85. Tai chi
  86. The Long Race Beating Cancer
  87. Thyroid guard: Do I need one during a mammogram?
  88. Tomosynthesis-guided breast biopsy
  89. Treatment options for metastatic breast cancer
  90. Ultrasound
  91. Sentinel node biopsy for melanoma
  92. Mammogram for breast cancer — What to expect
  93. MRI
  94. Tai chi
  95. Weight Loss After Breast Cancer
  96. What is metastatic breast cancer?
  97. Working with your doctor when you have metastatic breast cancer: Interview with a Mayo Clinic expert.
  98. X-ray
  99. Your secret weapon during cancer treatment? Exercise!